Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
George Hasko
Columbia University Health Sciences, Department: Anesthesiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Purine Pharmaceuticals
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Hasko is founder of a startup company called Purine Pharmaceuticals (that has licensed intellectual property from his former institution), and holds equity in this non-public company. Columbia has determined that the company’s aims (relating to sepsis) are related to the research in this R01; that the outcome of this research could affect the company or Dr. Hasko's significant financial interest in the company; and that the design, conduct, and/or reporting of this research could be affected by this financial interest.
Purinergic signaling in trauma and sepsis
RELEVANCE Sepsis is a devastating illness resulting in multiple organ failure and death and it is the leading cause of morbidity and mortality in critical care units in hospitals. We are studying the function of P2 adenosine triphosphate receptors, which are molecules found on the surface of immune cells, in regulating the course of sepsis. By elucidating how P2 receptors modulate immune and organ function during sepsis, we can utilize this information to develop new pharmacologic approaches targeting P2 receptors to treat patients suffering from sepsis.
Filed on September 21, 2018.
Tell us what you know about George Hasko's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.